Dr. Bruce Quinn Serves as Panelist at the Q1 Diagnostic Coverage and Reimbursement Conference

February 9, 2015

Dr. Bruce Quinn, Senior Health Policy Advisor at Foley Hoag LLP, served on a panel of professionals at a session of the Q1 Diagnostic Coverage and Reimbursement Conference on February 9 in San Diego, CA. “PAMA Update: Preparation for Laboratory Reporting Requirements” provided attendees with the most current information on the Protecting Access to Medicare Act of 2014 (PAMA). Dr. Quinn joined co-panelists Rina Wolf and Kyle Fetter of XIFIN, Julie Khani of ACLA, and Mark Birenbaum of NILA to discuss overall reporting implementation, execution and long-term financial impact of the new law on medical laboratories and diagnostic manufacturers.

At Foley Hoag, Dr. Quinn works with attorney and policy teams for healthcare and life sciences clients in the firm’s Government Strategies practice. He has worked successfully with companies in overcoming hurdles to commercialization through negotiation, understanding insightful ways to use the existing system to advantage and the mechanisms of policy change.

The Semi-Annual Diagnostic Coverage & Reimbursement Conference is geared toward executives involved in securing reimbursement for new or existing diagnostic tests. The two-day executive-level meeting provided participants with extensive learning and knowledge share through case studies, keynote sessions, round table panel discussions, and networking events.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and investment management fields, and in cross-border disputes. Our professionals  possess the skills  and experience to provide exceptional senior level service to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.